Amy L. Billett, MD

Associate Professor, Department of Pediatrics, Harvard Medical School

Clinical Associate, Pediatrics, Dana-Farber Cancer Institute

Associate in Medicine, Hematology-Oncology, Boston Children's Hospital

Contact Info

Amy Billett
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA, 02215
Mailstop: Shields Warren G360
Phone: 617-632-5640
Fax: 617-632-4811
amy_billett@dfci.harvard.edu

Assistant

Lyndsay Szymanski
Administrative Assistant
Pediatrics
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Phone: 617-632-5640
Fax: 617-632-4811
lyndsay_szymanski@dfci.harvard.edu

DF/HCC Program Affiliation

Lymphoma and Myeloma

Research Abstract

Our clinical research focuses on improving the long-term outcome for children with Hodgkin's disease. We also are involved in defining and measuring medication error, and developing systems to prevent it. Our other research interests include relapsed acute lymphoblastic leukemia (ALL) and chemotherapy-induced nausea and vomiting.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Amy L. Billett, MD Associate Professor, Department of Pediatrics, Harvard Medical School Clinical Associate, Pediatrics, Dana-Farber Cancer Institute Associate in Medicine, Hematology-Oncology, Boston Children's Hospital Contact Info Amy Billett Dana-Farber Cancer Institute 450 Brookline Avenue Boston, MA, 02215 Mailstop: Shields Warren G360 Phone: 617-632-5640 Fax: 617-632-4811 amy_billett@dfci.harvard.edu Assistant Lyndsay Szymanski Administrative Assistant Pediatrics Dana-Farber Cancer Institute 44 Binney Street Boston, MA, 02115 Phone: 617-632-5640 Fax: 617-632-4811 lyndsay_szymanski@dfci.harvard.edu DF/HCC Program Affiliation Lymphoma and Myeloma Research Abstract Our clinical research focuses on improving the long-term outcome for children with Hodgkin's disease. We also are involved in defining and measuring medication error, and developing systems to prevent it. Our other research interests include relapsed acute lymphoblastic leukemia (ALL) and chemotherapy-induced nausea and vomiting. Publications View All Publications
Site Map Site Feedback Web Privacy Policy